Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.60
Ask: 57.80
Change: -0.40 (-0.69%)
Spread: 1.20 (2.12%)
Open: 56.80
High: 57.00
Low: 56.80
Prev. Close: 57.60
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

29 Mar 2019 09:01

RNS Number : 4642U
Accsys Technologies PLC
29 March 2019
 

 

29 March 2019

AIM: AXS

Euronext Amsterdam: AXS

 

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Total Voting Rights

 

Further to the recent announcement of the issue of 70,175 new ordinary shares of €0.05 each in the capital of the Company pursuant to the Employment Benefit Trust, and pursuant to 5.6.1 of the Disclosure and Transparency Rules, the Company notifies the market of the following:

 

The issued share capital of the Company now consists of 117,988,305 ordinary shares of €0.05 each with voting rights. No ordinary shares are held in treasury.

 

The above figure of 117,988,305 ordinary shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules. This figure replaces and supersedes any figure previously announced.

 

 

ACCSYS TECHNOLOGIES PLC ("Accsys" of "de Vennootschap")

 

Totaal aantal stemrechten

 

Naar aanleiding van de recente aankondiging van de uitgifte van 70,175 nieuwe gewone aandelen in het kapitaal van de Vennootschap van € 0,05 per aandeel op grond van de Employment Benefit Trust, en in naleving van 5.6.1 van de Disclosure and Transparency Rules, informeert de Vennootschap de markt over het volgende:

 

Het uitgegeven aandelenkapitaal van de Vennootschap bestaat thans uit 117.988.305 gewone stemgerechtigde aandelen van € 0,05 per aandeel. Er is geen sprake van ingekochte eigen aandelen.

 

Het is aandeelhouders toegestaan het bovengenoemde getal van 117.988.305 gewone aandelen te gebruiken als deler bij berekeningen voor het bepalen van de noodzaak om hun belang, of een verandering in hun belang, in de Vennootschap te melden onder de Disclosure and Transparency Rules van de FCA. Dit getal vervangt alle eerder aangekondigde getallen.

 

 

Ends

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Will Rudge, FD

Hans Pauli, Executive Director, Corporate Development

via MHP Communications

Numis Securities

Nominated Adviser: Oliver Hardy

Corporate Broking: Christopher Wilkinson

Ben Stoop

+44 (0) 20 7260 1000

 

MHP Communications

Tim Rowntree

Kelsey Traynor

+44 (0) 20 3128 8100

 

Off the Grid

(The Netherlands)

Frank Neervoort

Yvonne Derske

+31 681 734 236

+31 222 379 666

 

Notes to editors:

 

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and Tricoya® wood elements, technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc.) and technology licensing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Accsys' operations comprise four principal business units: (i) Accoya® wood production; (ii) building and operating of Tricoya® wood chip acetylation plant in Hull; (iii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iv) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® Wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a highly sustainable and environmentally responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of naturally occurring 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

Accsys Technologies is the trading name of Titan Wood Limited. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRPGURAWUPBURB
Date   Source Headline
6th Aug 20147:00 amRNSSolvay global co-operation agreement
25th Jul 20147:00 amRNSDiamond Wood Licence Agreement
3rd Jul 20147:00 amRNSPreliminary results for the year ended March 2014
2nd Jul 20144:49 pmRNSNotifiable Interest
27th Jun 201412:00 pmRNSNotice of Results
2nd Jun 20147:00 amRNSMasisa Option Agreement Extended
7th May 20147:00 amRNSTrading Update
29th Apr 20147:05 amRNSNotice of Trading Update
29th Apr 20147:00 amRNSGordon Campbell CBE - Chairman
12th Feb 20147:47 amRNSReplacement: Interim Management Statement
12th Feb 20147:00 amRNSInterim Management Statement
31st Jan 201410:54 amRNSTotal Voting Rights
14th Jan 201411:01 amRNSAccsys Employee Share Participation Plan
10th Jan 20149:12 amRNSNotifiable Interest
23rd Dec 20137:00 amRNSACCOYA® LICENCE AGREEMENT WITH SOLVAY FORMALLY APP
25th Nov 20137:00 amRNSInterim Results
21st Nov 20133:01 pmRNSInterim results release date and webcast
20th Sep 20134:00 pmRNSLong Term Incentive Plan
19th Sep 20134:02 pmRNSAnnual General Meeting
19th Sep 20137:00 amRNSAGM Statement
30th Aug 20133:00 pmRNSTotal Voting Rights
28th Aug 20133:01 pmRNSNotice of AGM
16th Aug 20137:00 amRNSTermination of Diamond Wood licence agreement
1st Aug 20131:37 pmRNSAnnual Report and Financial Statements
1st Aug 20131:30 pmRNSTotal Voting Rights
30th Jul 20137:03 amRNSInterim Management Statement
23rd Jul 20133:59 pmRNSDirector/PDMR Shareholding
11th Jul 20137:00 amRNSAccsys JV signs Tricoya Licence Agreement
9th Jul 20131:25 pmRNSDirectors' Interests
28th Jun 20132:03 pmRNSNotifiable Interest
25th Jun 20137:00 amRNSAnnual Financial Report
21st Jun 20137:00 amRNSAnnual results release date and webcast
6th Jun 201310:17 amRNSAccsys joins the Social Stock Exchange
2nd May 20137:08 amRNSTrading update
14th Mar 20132:05 pmRNSDirector Information
20th Feb 201311:59 amRNSDirector's Interest
14th Feb 20137:04 amRNSInterim Management Statement
5th Feb 20134:40 pmRNSSecond Price Monitoring Extn
5th Feb 20134:35 pmRNSPrice Monitoring Extension
31st Jan 20139:02 amRNSTotal Voting Rights
25th Jan 20139:03 amRNSAnnual Information Update
16th Jan 20139:00 amRNSAccsys Employee Share Participation Plan
21st Nov 20128:13 amRNSInterim Results
16th Nov 20122:00 pmRNSInterim results release date and webcast
31st Oct 20124:16 pmRNSTotal Voting Rights
23rd Oct 201210:22 amRNSNotifiable Interest
23rd Oct 20129:17 amRNSPrestigous Awards and Certification
19th Oct 20127:07 amRNSAccsys-INEOS Tricoya(R) Joint Venture
8th Oct 20127:02 amRNSAccsys Completes Joint Venture With INEOS
1st Oct 20127:01 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.